Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826)
Hong Kong
· Delayed Price · Currency is HKD 26.30
-0.15 (-0.57%)
Jun 6, 2025, 4:08 PM HKT
HKG:6826 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 2,652 | 2,680 | 2,635 | 2,114 | 1,750 | 1,324 | Upgrade
|
| Other Revenue | - | - | - | 16.11 | - | - | Upgrade
|
| Revenue | 2,652 | 2,680 | 2,635 | 2,130 | 1,750 | 1,324 | Upgrade
|
| Revenue Growth (YoY) | -0.65% | 1.70% | 23.69% | 21.72% | 32.14% | -16.99% | Upgrade
|
| Cost of Revenue | 832.77 | 843.12 | 788.14 | 677.45 | 490.37 | 334 | Upgrade
|
| Gross Profit | 1,819 | 1,837 | 1,847 | 1,453 | 1,260 | 990.42 | Upgrade
|
| Selling, General & Admin | 1,228 | 1,228 | 1,237 | 1,073 | 898.43 | 772.49 | Upgrade
|
| Research & Development | 222.45 | 238.93 | 220.1 | 182.19 | 167.6 | 126.47 | Upgrade
|
| Other Operating Expenses | 0.53 | -2.23 | -1.97 | 7.89 | -3.18 | -1.37 | Upgrade
|
| Operating Expenses | 1,451 | 1,465 | 1,455 | 1,278 | 1,063 | 897.59 | Upgrade
|
| Operating Income | 368.84 | 372.03 | 391.79 | 174.67 | 196.9 | 92.83 | Upgrade
|
| Interest Expense | -17.91 | -18.06 | -7.3 | -7.6 | -4.96 | -4.91 | Upgrade
|
| Interest & Investment Income | 69.71 | 73.98 | 78.15 | 92.25 | 155.75 | 144.57 | Upgrade
|
| Earnings From Equity Investments | 0.99 | 0.99 | 0.46 | - | 2.19 | -0.13 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | - | -2.68 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 62.65 | 61.88 | 44.53 | -2.78 | 32.77 | 24.66 | Upgrade
|
| EBT Excluding Unusual Items | 484.28 | 490.81 | 507.63 | 253.86 | 382.65 | 257.03 | Upgrade
|
| Impairment of Goodwill | - | - | - | -9.57 | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.5 | - | - | -7.78 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.4 | - | 0.63 | 0.18 | - | - | Upgrade
|
| Asset Writedown | -7.16 | - | - | -36.5 | - | - | Upgrade
|
| Legal Settlements | -27.6 | -27.6 | - | - | - | - | Upgrade
|
| Other Unusual Items | 4.9 | 2.94 | - | 35.49 | - | - | Upgrade
|
| Pretax Income | 455.31 | 466.15 | 508.26 | 235.73 | 382.65 | 257.03 | Upgrade
|
| Income Tax Expense | 87.74 | 89.9 | 95.99 | 45.39 | 35.37 | 30.69 | Upgrade
|
| Earnings From Continuing Operations | 367.57 | 376.24 | 412.27 | 190.33 | 347.28 | 226.34 | Upgrade
|
| Minority Interest in Earnings | 45.65 | 44.2 | 3.85 | -9.86 | 4.95 | 3.73 | Upgrade
|
| Net Income | 413.22 | 420.45 | 416.12 | 180.47 | 352.23 | 230.07 | Upgrade
|
| Net Income to Common | 413.22 | 420.45 | 416.12 | 180.47 | 352.23 | 230.07 | Upgrade
|
| Net Income Growth | -4.46% | 1.04% | 130.58% | -48.76% | 53.10% | -37.95% | Upgrade
|
| Shares Outstanding (Basic) | 233 | 233 | 237 | 340 | 345 | 347 | Upgrade
|
| Shares Outstanding (Diluted) | 233 | 233 | 237 | 340 | 345 | 347 | Upgrade
|
| Shares Change (YoY) | 10.53% | -1.77% | -30.23% | -1.47% | -0.62% | 8.72% | Upgrade
|
| EPS (Basic) | 1.77 | 1.80 | 1.75 | 0.53 | 1.02 | 0.66 | Upgrade
|
| EPS (Diluted) | 1.77 | 1.80 | 1.75 | 0.53 | 1.02 | 0.66 | Upgrade
|
| EPS Growth | -13.56% | 2.86% | 230.47% | -48.00% | 54.06% | -42.93% | Upgrade
|
| Free Cash Flow | 388.58 | 284.39 | 368.85 | -85.85 | 71.41 | 72.38 | Upgrade
|
| Free Cash Flow Per Share | 1.67 | 1.22 | 1.55 | -0.25 | 0.21 | 0.21 | Upgrade
|
| Dividend Per Share | 1.000 | 1.000 | 0.510 | 0.286 | 0.500 | 0.357 | Upgrade
|
| Dividend Growth | 96.00% | 96.00% | 78.58% | -42.86% | 40.02% | -28.58% | Upgrade
|
| Gross Margin | 68.60% | 68.54% | 70.09% | 68.20% | 71.98% | 74.78% | Upgrade
|
| Operating Margin | 13.91% | 13.88% | 14.87% | 8.20% | 11.25% | 7.01% | Upgrade
|
| Profit Margin | 15.58% | 15.69% | 15.79% | 8.47% | 20.13% | 17.37% | Upgrade
|
| Free Cash Flow Margin | 14.65% | 10.61% | 14.00% | -4.03% | 4.08% | 5.46% | Upgrade
|
| EBITDA | 546.76 | 549.05 | 565.26 | 352.62 | 332.03 | 206.21 | Upgrade
|
| EBITDA Margin | 20.61% | 20.49% | 21.45% | 16.55% | 18.97% | 15.57% | Upgrade
|
| D&A For EBITDA | 177.92 | 177.03 | 173.47 | 177.94 | 135.13 | 113.38 | Upgrade
|
| EBIT | 368.84 | 372.03 | 391.79 | 174.67 | 196.9 | 92.83 | Upgrade
|
| EBIT Margin | 13.91% | 13.88% | 14.87% | 8.20% | 11.25% | 7.01% | Upgrade
|
| Effective Tax Rate | 19.27% | 19.29% | 18.89% | 19.26% | 9.24% | 11.94% | Upgrade
|
| Revenue as Reported | - | - | - | 2,130 | - | - | Upgrade
|
| Advertising Expenses | - | - | - | 37.31 | - | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.